Literature DB >> 12900438

Perturbation of D1 dopamine and AT1 receptor interaction in spontaneously hypertensive rats.

Chunyu Zeng1, Yingjin Luo, Laureano D Asico, Ulrich Hopfer, Gilbert M Eisner, Robin A Felder, Pedro A Jose.   

Abstract

The dopaminergic and renin-angiotensin systems interact to regulate blood pressure. Because this interaction may be perturbed in genetic hypertension, we studied D1 dopamine and AT1 angiotensin receptors in immortalized renal proximal tubule (RPT) and A10 aortic vascular smooth muscle cells. In normotensive Wistar-Kyoto (WKY) rats, the D1-like agonist fenoldopam increased D1 receptors but decreased AT1 receptors. These effects were blocked by the D1-like antagonist SCH 23390 (10(-7) mol/L per 24 hours). In spontaneously hypertensive rat (SHR) RPT cells, fenoldopam also decreased AT1 receptors but no longer stimulated D1 receptor expression. Basal levels of AT1/D1 receptor coimmunoprecipitation were greater in WKY RPT cells (29+/-2 density units, DU) than in SHR RPT cells (21+/-2 DU, n=7 per group, P<0.05). The coimmunoprecipitation of D1 and AT1 receptors was increased by fenoldopam (10(-7) mol/L per 24 hours) in WKY RPT cells but decreased in SHR RPT cells. The effects of fenoldopam in RPT cells from WKY rats were similar in aortic vascular smooth muscle cells from normotensive BD IX rats, that is, fenoldopam decreased AT1 receptors and increased D1 receptors. Our studies show differential regulation of the expression of D1 and AT1 receptors in RPT cells from WKY and SHR. This regulation and D1/AT1 receptor interaction are different in RPT cells of WKY and SHR. An altered interaction of D1 and AT1 receptors may play a role in the impaired sodium excretion and enhanced vasoconstriction in hypertension.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12900438     DOI: 10.1161/01.HYP.0000085334.34963.4E

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  38 in total

Review 1.  Pharmacology of signaling induced by dopamine D(1)-like receptor activation.

Authors:  Ashiwel S Undieh
Journal:  Pharmacol Ther       Date:  2010-06-12       Impact factor: 12.310

Review 2.  Dopamine Receptors and Neurodegeneration.

Authors:  Claudia Rangel-Barajas; Israel Coronel; Benjamín Florán
Journal:  Aging Dis       Date:  2015-10-01       Impact factor: 6.745

Review 3.  International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected].

Authors:  Sadashiva S Karnik; Hamiyet Unal; Jacqueline R Kemp; Kalyan C Tirupula; Satoru Eguchi; Patrick M L Vanderheyden; Walter G Thomas
Journal:  Pharmacol Rev       Date:  2015-10       Impact factor: 25.468

4.  Activation of the D4 dopamine receptor attenuates proliferation and migration of vascular smooth muscle cells through downregulation of AT1a receptor expression.

Authors:  Changqing Yu; Jianghua Chen; Weiwei Guan; Yu Han; Wei Eric Wang; Xukai Wang; Hongyong Wang; Pedro A Jose; Chunyu Zeng
Journal:  Hypertens Res       Date:  2015-04-02       Impact factor: 3.872

5.  Strategy for the development of a matched set of transport-competent, angiotensin receptor-deficient proximal tubule cell lines.

Authors:  Philip G Woost; Robert J Kolb; Margaret Finesilver; Irene Mackraj; Hans Imboden; Thomas M Coffman; Ulrich Hopfer
Journal:  In Vitro Cell Dev Biol Anim       Date:  2006 Jul-Aug       Impact factor: 2.416

Review 6.  Dopamine receptors: important antihypertensive counterbalance against hypertensive factors.

Authors:  Chunyu Zeng; Pedro A Jose
Journal:  Hypertension       Date:  2010-11-22       Impact factor: 10.190

Review 7.  G protein-coupled receptor kinase 4: role in blood pressure regulation.

Authors:  Chunyu Zeng; Van Anthony M Villar; Gilbert M Eisner; Scott M Williams; Robin A Felder; Pedro A Jose
Journal:  Hypertension       Date:  2008-03-17       Impact factor: 10.190

Review 8.  Renal dopamine and angiotensin II receptor signaling in age-related hypertension.

Authors:  Gaurav Chugh; Indira Pokkunuri; Mohammad Asghar
Journal:  Am J Physiol Renal Physiol       Date:  2012-10-24

9.  Effects of decreased renal cortical expression of G protein-coupled receptor kinase 4 and angiotensin type 1 receptors in rats.

Authors:  Junichi Yatabe; Hironobu Sanada; Sanae Midorikawa; Shigeatsu Hashimoto; Tsuyoshi Watanabe; Peter M Andrews; Ines Armando; Xiaoyan Wang; Robin A Felder; Pedro A Jose
Journal:  Hypertens Res       Date:  2008-07       Impact factor: 3.872

10.  A linear relationship between the ex-vivo sodium mediated expression of two sodium regulatory pathways as a surrogate marker of salt sensitivity of blood pressure in exfoliated human renal proximal tubule cells: the virtual renal biopsy.

Authors:  John J Gildea; Dylan T Lahiff; Robert E Van Sciver; Ryan S Weiss; Neema Shah; Helen E McGrath; Cynthia D Schoeffel; Pedro A Jose; Robert M Carey; Robin A Felder
Journal:  Clin Chim Acta       Date:  2013-02-27       Impact factor: 3.786

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.